An experimental Ebola treatment by a Japanese company says it is "not a miracle drug", but offers new hope for thousands of people infected with the deadly virus in west Africa. In their first comments to media since the release of early clinical trials last week, executives from Fujifilm's drug unit Toyama Chemical said the results were a "good first step" that could lead to larger and better-designed trials. Avigan -- approved for use in Japan as an ...
http://ift.tt/1zRRnXP
http://ift.tt/1BWgEAm
No comments:
Post a Comment